New developments around histamine H₃ receptor antagonists/inverse agonists: a patent review (2010 – present)

Author： Łażewska Dorota Kieć-Kononowicz Katarzyna

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.24, Iss.1, 2014-01, pp. : 89-111

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent advances in histamine H₃ receptor antagonists/inverse agonists

By Łażewska Dorota Kieć-Kononowicz Katarzyna

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 9, 2010-09 ,pp. : 1147-1169

Informa Healthcare

Access to resources Recommend Favorite

The Evolution of Histamine H3 Antagonists/Inverse Agonists

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 6, 2011-03 ,pp. : 648-660

Bentham Science Publishers

Access to resources Recommend Favorite

Assessment of pharmacology and potential anti-obesity properties of H₃ receptor antagonists/inverse agonists

By Hancock Arthur A Brune Michael E

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 3, 2005-03 ,pp. : 223-241

Informa Healthcare

Access to resources Recommend Favorite

Histamine H3 Receptor (H3R) Antagonists and Inverse Agonists in the Treatment of Sleep Disorders

Current Pharmaceutical Design, Vol. 17, Iss. 15, 2011-05 ,pp. : 1426-1429

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of histamine H 3 receptor agonists and antagonists

By Leurs R. Blandina P. Tedford C. Timmerman H.

Trends in Pharmacological Sciences, Vol. 19, Iss. 5, 1998-05 ,pp. : 177-184

Elsevier

Access to resources Recommend Favorite